Literature DB >> 28904049

Use of thyroid-stimulating hormone tests for identifying primary hypothyroidism in family medicine patients.

Elizabeth Birk-Urovitz1, M Elisabeth Del Giudice2, Christopher Meaney3, Karan Grewal4.   

Abstract

OBJECTIVE: To assess the use of thyroid-stimulating hormone (TSH) tests for identifying primary hypothyroidism in 2 academic family medicine settings.
DESIGN: Descriptive study involving a retrospective electronic chart review of family medicine patients who underwent TSH testing.
SETTING: Two academic family practice sites: one site is within a tertiary hospital in Toronto, Ont, and the other is within a community hospital in Newmarket, Ont. PARTICIPANTS: A random sample of 205 adult family medicine patients who had 1 or more TSH tests for identifying potential primary hypothyroidism between July 1, 2009, and September 15, 2013. Exclusion criteria included a previous diagnosis of any thyroid condition or abnormality, as well as pregnancy or recent pregnancy within the year preceding the study period. MAIN OUTCOME MEASURES: The proportion of normal TSH test results and the proportion of TSH tests that did not conform to test-ordering guidelines.
RESULTS: Of the 205 TSH test results, 200 (97.6%, 95% CI 94.4% to 99.2%) showed TSH levels within the normal range. All 5 patients with abnormal TSH test results had TSH levels above the upper reference limits. Nearly one-quarter (22.4%, 95% CI 16.9% to 28.8%) of tests did not conform to test-ordering guidelines. All TSH tests classified as not conforming to test-ordering guidelines showed TSH levels within normal limits. There was a significant difference (P < .001) between the proportions of nonconforming TSH tests at the tertiary site (14.3%, 95% CI 8.2% to 22.5%) and the community site (31.0%, 95% CI 22.1% to 41.0%). Preliminary analyses examining which variables might be associated with abnormal TSH levels showed that only muscle cramps or myalgia (P = .0286) and a history of an autoimmune disorder (P = .0623) met or approached statistical significance.
CONCLUSION: In this study, the proportion of normal TSH test results in the context of primary hypothyroidism case finding and screening was high, and the overall proportion of TSH tests that did not conform to test-ordering guidelines was relatively high as well. These results highlight a need for more consistent TSH test-ordering guidelines for primary hypothyroidism and perhaps some educational interventions to help curtail the overuse of TSH tests in the family medicine setting. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28904049      PMCID: PMC5597029     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  10 in total

1.  Are thyroid function tests too frequently and inappropriately requested?

Authors:  E Roti; E Gardini; M G Magotti; S Pilla; R Minelli; M Salvi; C Monica; D Maestri; S Cencetti; L E Braverman
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

2.  Utilization of laboratory resources: developments in knowledge-based ordering systems.

Authors:  L Boon-Falleur; E Sokal; P G Nightingale; M Peters; J B Otte; J M Ketelslegers; E De Wilde; A Hasman
Journal:  Int J Biomed Comput       Date:  1995-09

3.  Thyroid disease in middle-aged and elderly Swedish women: thyroid-related hormones, thyroid dysfunction and goitre in relation to age and smoking.

Authors:  K Petersen; G Lindstedt; P A Lundberg; C Bengtsson; L Lapidus; E Nyström
Journal:  J Intern Med       Date:  1991-05       Impact factor: 8.989

4.  American Thyroid Association guidelines for detection of thyroid dysfunction.

Authors:  P W Ladenson; P A Singer; K B Ain; N Bagchi; S T Bigos; E G Levy; S A Smith; G H Daniels; H D Cohen
Journal:  Arch Intern Med       Date:  2000-06-12

5.  Use of sensitive immunoradiometric assay for thyrotropin in clinical practice.

Authors:  A D Toft
Journal:  Mayo Clin Proc       Date:  1988-10       Impact factor: 7.616

6.  Use of a single thyroxine test to evaluate ambulatory medical patients for suspected hypothyroidism.

Authors:  B J Goldstein; A I Mushlin
Journal:  J Gen Intern Med       Date:  1987 Jan-Feb       Impact factor: 5.128

7.  Cost-effectiveness of thyroid function tests.

Authors:  J R Drake; D K Miller; R G Evans
Journal:  Arch Intern Med       Date:  1982-10

Review 8.  Management of thyroid disorders in primary care: challenges and controversies.

Authors:  C H Todd
Journal:  Postgrad Med J       Date:  2009-12       Impact factor: 2.401

9.  Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association.

Authors:  Jeffrey R Garber; Rhoda H Cobin; Hossein Gharib; James V Hennessey; Irwin Klein; Jeffrey I Mechanick; Rachel Pessah-Pollack; Peter A Singer; Kenneth A Woeber
Journal:  Thyroid       Date:  2012-11-06       Impact factor: 6.568

10.  Accuracy of physical examination in the diagnosis of hypothyroidism: a cross-sectional, double-blind study.

Authors:  R Indra; S S Patil; R Joshi; M Pai; S P Kalantri
Journal:  J Postgrad Med       Date:  2004 Jan-Mar       Impact factor: 1.476

  10 in total
  7 in total

1.  Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care.

Authors:  Richard Birtwhistle; Kate Morissette; James A Dickinson; Donna L Reynolds; Marc T Avey; Francesca Reyes Domingo; Rachel Rodin; Brett D Thombs
Journal:  CMAJ       Date:  2019-11-18       Impact factor: 8.262

2.  Choosing Wisely Canada campaign associated with less overuse of thyroid testing: Retrospective parallel cohort study.

Authors:  Kimberly Wintemute; Michelle Greiver; Warren McIsaac; M Elisabeth Del Giudice; Frank Sullivan; Babak Aliarzadeh; Sumeet Kalia; Chris Meaney; Rahim Moineddin; Alexander Singer
Journal:  Can Fam Physician       Date:  2019-11       Impact factor: 3.275

Review 3.  The impact of the management strategies for patients with subclinical hypothyroidism on long-term clinical outcomes: An umbrella review.

Authors:  Brenda S Bauer; Amaya Azcoaga-Lorenzo; Utkarsh Agrawal; Adeniyi Francis Fagbamigbe; Colin McCowan
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

4.  Trends in thyroid function testing, neck ultrasound, thyroid fine needle aspiration, and thyroidectomies in North-eastern Italy.

Authors:  L Dal Maso; C Panato; A De Paoli; V Mattioli; D Serraino; R Elisei; G Zoppini; C Gobitti; E Borsatti; E Di Felice; F Falcini; S Ferretti; S Francisci; P Giorgi Rossi; S Guzzinati; G Mazzoleni; D Pierannunzio; S Piffer; S Vaccarella; M Vicentini; M Zorzi; S Franceschi; U Fedeli
Journal:  J Endocrinol Invest       Date:  2021-01-18       Impact factor: 4.256

5.  Adoption of a laboratory EMR system and inappropriate laboratory testing in Ontario: a cross-sectional observational study.

Authors:  Nadine Chami; Silvy Mathew; Sharada Weir; James G Wright; Jasmin Kantarevic
Journal:  BMC Health Serv Res       Date:  2021-04-06       Impact factor: 2.655

6.  Inappropriate use of clinical practices in Canada: a systematic review.

Authors:  Janet E Squires; Danielle Cho-Young; Laura D Aloisio; Robert Bell; Stephen Bornstein; Susan E Brien; Simon Decary; Melissa Demery Varin; Mark Dobrow; Carole A Estabrooks; Ian D Graham; Megan Greenough; Doris Grinspun; Michael Hillmer; Tanya Horsley; Jiale Hu; Alan Katz; Christina Krause; John Lavis; Wendy Levinson; Adrian Levy; Michelina Mancuso; Steve Morgan; Letitia Nadalin-Penno; Andrew Neuner; Tamara Rader; Wilmer J Santos; Gary Teare; Joshua Tepper; Amanda Vandyk; Michael Wilson; Jeremy M Grimshaw
Journal:  CMAJ       Date:  2022-02-28       Impact factor: 16.859

7.  Changes of nutritional status and the variations of serum indicators of patients with chronic kidney disease accompanied by hypothyroidism taking thyroid hormone replacement therapy as the therapeutic models.

Authors:  Xin Deng; Cai Tang; Jinlin Wu; Rui Han; Fang Fang
Journal:  Saudi J Biol Sci       Date:  2019-09-24       Impact factor: 4.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.